News & Events

Understanding and taming the costs of diseases associated to the gut microbiota disruption has always been a priority for Da…

The 4th Annual North America Microbiome Congress in Washington DC, by Kisaco Research, has become a trusted learning and networking…

Da Volterra pleased to attend the ‘3rd Microbiome Movement – Drug Development Europe 2019’ conference taking place in Paris, on…

Paris (France), 20 December, 2018 – Da Volterra, a clinical-stage microbiome company focused on developing new therapeutics to protect the intestinal…

Meet Florence Séjourné, CEO of Da Volterra, at J.P. Morgan Healthcare Conference, the largest and most informative Healthcare Investment Symposium…

Da Volterra is pleased to sponsor the 6th Annual International C.Diff Awareness Conference organised by the C DIFF Foundation and…

The poster entitled “Perception of Quality of Life Among People Experiencing or Having Experienced a Clostridium difficile Infection in the…

Meet Da Volterra at BIO Europe 2018 in Copenhagen, the Europe’s largest partnering conference serving the global biotechnology industry! We…

The US Patent and Trademark Office has recently granted a new patent for Da Volterra in the USA. The patent…

Da Volterra is proud to be part of the sponsors of the 9th annual Fight C. Diff Gala organised by…